BOSTON SCIENTIFIC TO ADD CARDIAC ABLATION SYSTEM WITH $150 MIL. STOCK OFFER FOR EP TECHNOLOGIES; CAN SHOPPING SPREE CONTINUE? 6 DEALS IN 14 MONTHS
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's $150 mil. proposed merger with EP Technologies would add one of the two radiofrequency catheter systems with FDA approval for therapeutic ablation to Boston Scientific's rapidly expanding portfolio of minimally invasive devices. On Oct. 9, the firms announced a definitive agreement with an expected closing during the first quarter of 1996.